Proteintech
anti γ tubulin Anti γ Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti γ tubulin/product/Proteintech Average 94 stars, based on 1 article reviews
anti γ tubulin - by Bioz Stars,
2025-07
94/100 stars
|
Buy from Supplier |
Proteintech
plk4 rnai treatment Plk4 Rnai Treatment, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/plk4 rnai treatment/product/Proteintech Average 94 stars, based on 1 article reviews
plk4 rnai treatment - by Bioz Stars,
2025-07
94/100 stars
|
Buy from Supplier |
Proteintech
anti plk4 ![]() Anti Plk4, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti plk4/product/Proteintech Average 94 stars, based on 1 article reviews
anti plk4 - by Bioz Stars,
2025-07
94/100 stars
|
Buy from Supplier |
Proteintech
plk4 ![]() Plk4, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/plk4/product/Proteintech Average 94 stars, based on 1 article reviews
plk4 - by Bioz Stars,
2025-07
94/100 stars
|
Buy from Supplier |
WuXi AppTec
12952 svpascrl male ![]() 12952 Svpascrl Male, supplied by WuXi AppTec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/12952 svpascrl male/product/WuXi AppTec Average 86 stars, based on 1 article reviews
12952 svpascrl male - by Bioz Stars,
2025-07
86/100 stars
|
Buy from Supplier |
Proteintech
human fam161a a plk4 ![]() Human Fam161a A Plk4, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human fam161a a plk4/product/Proteintech Average 94 stars, based on 1 article reviews
human fam161a a plk4 - by Bioz Stars,
2025-07
94/100 stars
|
Buy from Supplier |
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A The mRNA expression of PLK4 in EC cell lines. B The protein expression of PLK4 in EC cell lines. C The mRNA expression of PLK4 in KIFC1-overexpressed HEC-1A and KIFC1-knockdown Ishikawa cells. D The protein expression of PLK4 in KIFC1-overexpressed HEC-1A and KIFC1-knockdown Ishikawa cells. E The mRNA expressions of PLK4 and KIFC1 in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). F The protein expressions of PLK4 and KIFC1 in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). G The immunofluorescence analysis with γ-tubulin and α-tubulin antibodies in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa) (scale bar: 10 μm). * P < 0.05, ** P < 0.01, # P < 0.05, ## P < 0.01.
Article Snippet: The antibodies anti-KIFC1 (1:200, No. 20790-1-AP, Proteintech),
Techniques: Expressing, Knockdown, Immunofluorescence
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A CCK8 assay in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). B Colony formation assay in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). C Transwell assay and quantitative analysis of migratory and invasive abilities of PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa) (scale bar: 100 μm). ** P < 0.01, ## P < 0.01.
Article Snippet: The antibodies anti-KIFC1 (1:200, No. 20790-1-AP, Proteintech),
Techniques: CCK-8 Assay, Knockdown, Colony Assay, Transwell Assay
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A CHX chase analysis of PLK4 protein half-life after KIFC1 overexpression and knockdown in EC cell lines (HEC-1A and Ishikawa). B The protein expression of KIFC1 and PLK4 in HEC-1A and Ishikawa cells treated with MG132 or CQ after KIFC1 knockdown. C Results of the ubiquitination level of PLK4 in HEK293T cells after KIFC1 overexpression detected by ubiquitination assay. ** P < 0.01, ## P < 0.01, ^^ P < 0.01.
Article Snippet: The antibodies anti-KIFC1 (1:200, No. 20790-1-AP, Proteintech),
Techniques: Over Expression, Knockdown, Expressing, Ubiquitin Assay
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A The mRNA and protein expressions of TRIM37 in KIFC1-overexpressed HEC-1A and KIFC1-knockdown Ishikawa cells. B The mRNA and protein expressions of TRIM37 in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). C Results of the ubiquitination level of PLK4 in HEK293T cells after KIFC1 or TRIM37 overexpression detected by ubiquitination assay. D The mRNA expressions of KIFC1, TRIM37, and PLK4 in TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa). E CCK8 assay in TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa). F Colony formation assay in TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa). G Transwell assay and quantitative analysis of migratory and invasive abilities of TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa) (scale bar: 100 μm). H The protein expressions of KIFC1, TRIM37, and PLK4 in TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa). * P < 0.05, ** P < 0.01, # P < 0.05, ## P < 0.01.
Article Snippet: The antibodies anti-KIFC1 (1:200, No. 20790-1-AP, Proteintech),
Techniques: Knockdown, Over Expression, Ubiquitin Assay, CCK-8 Assay, Colony Assay, Transwell Assay
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A General images of mice and tumors in the subcutaneous xenograft of HEC-1A cells after TRIM37 and KIFC1 overexpression. B The tumor volume and weight. C Representative H & E staining and IHC staining of Ki-67, KIFC1, TRIM37, and PLK4 in tumors (scale bar: 200 μm for left; 100 μm for right). D Representative TUNEL images of tumors (scale bar: 200 μm for left; 100 μm for right). E Representative H & E staining images of lung tissues (scale bar: 200 μm for left; 100 μm for right); F Fluorescence images (left) and quantitative analysis (right) of mouse lung metastasis. * P < 0.05, ** P < 0.01, # P < 0.05, ## P < 0.01.
Article Snippet: The antibodies anti-KIFC1 (1:200, No. 20790-1-AP, Proteintech),
Techniques: Over Expression, Staining, Immunohistochemistry, TUNEL Assay, Fluorescence
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A The mRNA expression of PLK4 in EC cell lines. B The protein expression of PLK4 in EC cell lines. C The mRNA expression of PLK4 in KIFC1-overexpressed HEC-1A and KIFC1-knockdown Ishikawa cells. D The protein expression of PLK4 in KIFC1-overexpressed HEC-1A and KIFC1-knockdown Ishikawa cells. E The mRNA expressions of PLK4 and KIFC1 in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). F The protein expressions of PLK4 and KIFC1 in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). G The immunofluorescence analysis with γ-tubulin and α-tubulin antibodies in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa) (scale bar: 10 μm). * P < 0.05, ** P < 0.01, # P < 0.05, ## P < 0.01.
Article Snippet: The blots were then blocked in 5% nonfat dry milk solution (Beyotime Biotechnology, Shanghai) at room temperature for 1 h. Subsequently, the blots were incubated with the following primary antibodies: KIFC1 (1:1000, No. 20790-1-AP, Proteintech), γ-tubulin (1:5000, No. 66320-1-Ig, Proteintech), p-H3 (S10) (1:1000, #9701, Cell Signaling Technology), Cyclin A2 (1:1000, #67955, Cell Signaling Technology), Cyclin B1 (1:1000, #4138, Cell Signaling Technology), CDK1 (1:10000, No. 10122-1-AP, Proteintech), CDC2 (1:1000, #77055, Cell Signaling Technology),
Techniques: Expressing, Knockdown, Immunofluorescence
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A CCK8 assay in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). B Colony formation assay in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). C Transwell assay and quantitative analysis of migratory and invasive abilities of PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa) (scale bar: 100 μm). ** P < 0.01, ## P < 0.01.
Article Snippet: The blots were then blocked in 5% nonfat dry milk solution (Beyotime Biotechnology, Shanghai) at room temperature for 1 h. Subsequently, the blots were incubated with the following primary antibodies: KIFC1 (1:1000, No. 20790-1-AP, Proteintech), γ-tubulin (1:5000, No. 66320-1-Ig, Proteintech), p-H3 (S10) (1:1000, #9701, Cell Signaling Technology), Cyclin A2 (1:1000, #67955, Cell Signaling Technology), Cyclin B1 (1:1000, #4138, Cell Signaling Technology), CDK1 (1:10000, No. 10122-1-AP, Proteintech), CDC2 (1:1000, #77055, Cell Signaling Technology),
Techniques: CCK-8 Assay, Knockdown, Colony Assay, Transwell Assay
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A CHX chase analysis of PLK4 protein half-life after KIFC1 overexpression and knockdown in EC cell lines (HEC-1A and Ishikawa). B The protein expression of KIFC1 and PLK4 in HEC-1A and Ishikawa cells treated with MG132 or CQ after KIFC1 knockdown. C Results of the ubiquitination level of PLK4 in HEK293T cells after KIFC1 overexpression detected by ubiquitination assay. ** P < 0.01, ## P < 0.01, ^^ P < 0.01.
Article Snippet: The blots were then blocked in 5% nonfat dry milk solution (Beyotime Biotechnology, Shanghai) at room temperature for 1 h. Subsequently, the blots were incubated with the following primary antibodies: KIFC1 (1:1000, No. 20790-1-AP, Proteintech), γ-tubulin (1:5000, No. 66320-1-Ig, Proteintech), p-H3 (S10) (1:1000, #9701, Cell Signaling Technology), Cyclin A2 (1:1000, #67955, Cell Signaling Technology), Cyclin B1 (1:1000, #4138, Cell Signaling Technology), CDK1 (1:10000, No. 10122-1-AP, Proteintech), CDC2 (1:1000, #77055, Cell Signaling Technology),
Techniques: Over Expression, Knockdown, Expressing, Ubiquitin Assay
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A The mRNA and protein expressions of TRIM37 in KIFC1-overexpressed HEC-1A and KIFC1-knockdown Ishikawa cells. B The mRNA and protein expressions of TRIM37 in PLK4-overexpressed and KIFC1-knockdown EC cell lines (HEC-1A and Ishikawa). C Results of the ubiquitination level of PLK4 in HEK293T cells after KIFC1 or TRIM37 overexpression detected by ubiquitination assay. D The mRNA expressions of KIFC1, TRIM37, and PLK4 in TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa). E CCK8 assay in TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa). F Colony formation assay in TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa). G Transwell assay and quantitative analysis of migratory and invasive abilities of TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa) (scale bar: 100 μm). H The protein expressions of KIFC1, TRIM37, and PLK4 in TRIM37- and KIFC1-overexpressed EC cell lines (HEC-1A and Ishikawa). * P < 0.05, ** P < 0.01, # P < 0.05, ## P < 0.01.
Article Snippet: The blots were then blocked in 5% nonfat dry milk solution (Beyotime Biotechnology, Shanghai) at room temperature for 1 h. Subsequently, the blots were incubated with the following primary antibodies: KIFC1 (1:1000, No. 20790-1-AP, Proteintech), γ-tubulin (1:5000, No. 66320-1-Ig, Proteintech), p-H3 (S10) (1:1000, #9701, Cell Signaling Technology), Cyclin A2 (1:1000, #67955, Cell Signaling Technology), Cyclin B1 (1:1000, #4138, Cell Signaling Technology), CDK1 (1:10000, No. 10122-1-AP, Proteintech), CDC2 (1:1000, #77055, Cell Signaling Technology),
Techniques: Knockdown, Over Expression, Ubiquitin Assay, CCK-8 Assay, Colony Assay, Transwell Assay
Journal: Cell Death Discovery
Article Title: KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer
doi: 10.1038/s41420-024-02190-1
Figure Lengend Snippet: A General images of mice and tumors in the subcutaneous xenograft of HEC-1A cells after TRIM37 and KIFC1 overexpression. B The tumor volume and weight. C Representative H & E staining and IHC staining of Ki-67, KIFC1, TRIM37, and PLK4 in tumors (scale bar: 200 μm for left; 100 μm for right). D Representative TUNEL images of tumors (scale bar: 200 μm for left; 100 μm for right). E Representative H & E staining images of lung tissues (scale bar: 200 μm for left; 100 μm for right); F Fluorescence images (left) and quantitative analysis (right) of mouse lung metastasis. * P < 0.05, ** P < 0.01, # P < 0.05, ## P < 0.01.
Article Snippet: The blots were then blocked in 5% nonfat dry milk solution (Beyotime Biotechnology, Shanghai) at room temperature for 1 h. Subsequently, the blots were incubated with the following primary antibodies: KIFC1 (1:1000, No. 20790-1-AP, Proteintech), γ-tubulin (1:5000, No. 66320-1-Ig, Proteintech), p-H3 (S10) (1:1000, #9701, Cell Signaling Technology), Cyclin A2 (1:1000, #67955, Cell Signaling Technology), Cyclin B1 (1:1000, #4138, Cell Signaling Technology), CDK1 (1:10000, No. 10122-1-AP, Proteintech), CDC2 (1:1000, #77055, Cell Signaling Technology),
Techniques: Over Expression, Staining, Immunohistochemistry, TUNEL Assay, Fluorescence
Journal: Cell
Article Title: Time-series reconstruction of the molecular architecture of human centriole assembly
doi: 10.1016/j.cell.2024.03.025
Figure Lengend Snippet: Steps of procentriole initiation (A–B′) Centrosomes stained for tubulin and SAS-6 (A and A′) or STIL (B and B′). Arrowheads indicate the presence of SAS-6 (A) and STIL (B) in absence of tubulin signal (A′ and B′), thereafter called “naked.” MC, mature centriole. Scale bars: 200 nm. (C) Percentage of cells presenting a signal for PLK4, SAS-6, STIL, CPAP, CEP135, and CEP44 at the level of the future procentriole in the absence of a tubulin signal. See
Article Snippet:
Techniques: Staining
Journal: Cell
Article Title: Time-series reconstruction of the molecular architecture of human centriole assembly
doi: 10.1016/j.cell.2024.03.025
Figure Lengend Snippet: Methodology of the naked cartwheel observation, related to
Article Snippet:
Techniques: Staining
Journal: Cell
Article Title: Time-series reconstruction of the molecular architecture of human centriole assembly
doi: 10.1016/j.cell.2024.03.025
Figure Lengend Snippet: Procentriole elongation (A and B) Centrioles during assembly and at mature stage stained for tubulin (A) and (B) and SAS-6 (A) or γ-tubulin (B). Scale bars: 200 nm. (C) “Average” procentrioles (180–200 nm in length) stained for tubulin and γ-tubulin, PLK4, CEP135, CEP44, SAS-6, STIL, and CPAP. Asterisks indicate additional distal localization of CPAP and CEP135. (D) Relative protein longitudinal and radial positions compared with tubulin. See
Article Snippet:
Techniques: Staining
Journal: Cell
Article Title: Time-series reconstruction of the molecular architecture of human centriole assembly
doi: 10.1016/j.cell.2024.03.025
Figure Lengend Snippet: Growth rate of the cartwheel and pinhead components, related to
Article Snippet:
Techniques:
Journal: Cell
Article Title: Time-series reconstruction of the molecular architecture of human centriole assembly
doi: 10.1016/j.cell.2024.03.025
Figure Lengend Snippet:
Article Snippet:
Techniques: Recombinant, Software